Consistent with prior analyses, researchers determined, “There was no evidence that RML [recreational marijuana laws] were associated with encouraging youth marijuana use.”
Tag: JAMA
“Together, results found no net increases in cannabis or, through spillover effects, alcohol or tobacco use among adolescents in response to the rapid rise of RCL [recreational cannabis legalization] and RCR [recreational cannabis retail sales]. Results suggest that legalization and greater control over cannabis markets have not facilitated adolescents’ entry into substance use.”
Two new studies published online today in JAMA (Journal of the American Medical Association) Psychiatry provide little support for previous claims that cannabis exposure is significantly harmful to the developing brain.
Drug policy reform advocates pen letter-to-the-editor to Journal of the American Medical Association (JAMA) encouraging them to not confuse specific cannabinoid research with whole cannabis products in general as an effective and safe medicinal therapeutic.
The enactment of medicinal marijuana laws is associated with significantly lower state-level opioid overdose mortality rates, according to data published online today by the Journal of the American Medical Association. Researchers reported, “States with medical cannabis laws had a 24.8% lower mean annual opioid overdose mortality rate compared with states without medical cannabis laws. … Although the exact mechanism is unclear, our results suggest a link between medical cannabis laws and lower opioid analgesic overdose mortality.”
Exposure to cannabis smoke, even over the long-term, is not associated with adverse effects on…